HEADER RNA BINDING PROTEIN 25-MAY-11 3S6E TITLE CRYSTAL STRUCTURE OF A RNA BINDING MOTIF PROTEIN 39 (RBM39) FROM MUS TITLE 2 MUSCULUS AT 0.95 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-BINDING PROTEIN 39; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 418-530; COMPND 5 SYNONYM: COACTIVATOR OF ACTIVATING PROTEIN 1 AND ESTROGEN RECEPTORS, COMPND 6 COACTIVATOR OF AP-1 AND ERS, RNA-BINDING MOTIF PROTEIN 39, RNA- COMPND 7 BINDING REGION-CONTAINING PROTEIN 2, TRANSCRIPTION COACTIVATOR CAPER; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: BC030493, CAPER, RBM39, RNPC2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS FERREDOXIN-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, RNA KEYWDS 3 BINDING PROTEIN, PARTNERSHIP FOR T-CELL BIOLOGY, TCELL EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),PARTNERSHIP FOR T-CELL AUTHOR 2 BIOLOGY (TCELL) REVDAT 5 01-FEB-23 3S6E 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3S6E 1 REMARK REVDAT 3 21-OCT-15 3S6E 1 AUTHOR JRNL REVDAT 2 10-AUG-11 3S6E 1 ATOM DBREF REMARK VERSN REVDAT 1 15-JUN-11 3S6E 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG), JRNL AUTH 2 PARTNERSHIP FOR T-CELL BIOLOGY (TCELL) JRNL TITL CRYSTAL STRUCTURE OF A RNA BINDING MOTIF PROTEIN 39 (RBM39) JRNL TITL 2 FROM MUS MUSCULUS AT 0.95 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 0.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 130918 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.120 REMARK 3 R VALUE (WORKING SET) : 0.119 REMARK 3 FREE R VALUE : 0.132 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6590 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 0.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 0.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 8765 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 450 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1718 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 386 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.17000 REMARK 3 B22 (A**2) : 0.56000 REMARK 3 B33 (A**2) : -0.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.018 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.018 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.011 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.453 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.983 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.981 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2065 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1333 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2882 ; 1.832 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3349 ; 1.222 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 303 ; 5.777 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;36.779 ;25.978 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 343 ;11.882 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ; 8.950 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 327 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2410 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 386 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1283 ; 1.997 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 500 ; 1.107 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2124 ; 2.904 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 782 ; 2.883 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 722 ; 4.070 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3398 ; 1.423 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 447 ; 9.303 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3311 ; 4.418 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3.CITRATE (CIT) FROM THE CRYSTALLIZATION SOLUTION REMARK 3 AND GLYCEROL (GOL) FROM THE CRYOPROTECTANT SOLUTION HAVE BEEN REMARK 3 MODELED IN THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3S6E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065818. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95369,0.97915 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR; DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 131023 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.950 REMARK 200 RESOLUTION RANGE LOW (A) : 28.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : 0.67000 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.00% POLYETHYLENE GLYCOL 6000, 0.1M REMARK 280 SODIUM CITRATE PH 5.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.35050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.30050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.56950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.30050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.35050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.56950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY AND CRYSTAL REMARK 300 PACKING ANALYSIS SUPPORT THE ASSIGNMENT OF A MONOMER AS A REMARK 300 SIGNIFICANT 300 OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLY B 0 REMARK 465 VAL B 418 REMARK 465 ARG B 530 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 530 NE CZ NH1 NH2 REMARK 470 GLN B 419 CG CD OE1 NE2 REMARK 470 GLN B 435 CG CD OE1 NE2 REMARK 470 GLU B 445 CD OE1 OE2 REMARK 470 ARG B 529 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER B 469 CA - C - N ANGL. DEV. = 15.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 457 -109.33 -135.88 REMARK 500 HIS B 457 -98.62 -130.71 REMARK 500 ALA B 470 15.18 41.88 REMARK 500 GLN B 471 9.86 -156.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT B 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 421759 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 418-530 OF THE TARGET REMARK 999 SEQUENCE. NUMBERING IS BASED ON ISOFORM 1 OF UNIPROTKB Q8VH51. DBREF 3S6E A 418 530 UNP Q8VH51 RBM39_MOUSE 418 530 DBREF 3S6E B 418 530 UNP Q8VH51 RBM39_MOUSE 418 530 SEQADV 3S6E GLY A 0 UNP Q8VH51 EXPRESSION TAG SEQADV 3S6E GLY B 0 UNP Q8VH51 EXPRESSION TAG SEQRES 1 A 114 GLY VAL GLN PRO LEU ALA THR GLN CYS PHE GLN LEU SER SEQRES 2 A 114 ASN MSE PHE ASN PRO GLN THR GLU GLU GLU VAL GLY TRP SEQRES 3 A 114 ASP THR GLU ILE LYS ASP ASP VAL ILE GLU GLU CYS ASN SEQRES 4 A 114 LYS HIS GLY GLY VAL ILE HIS ILE TYR VAL ASP LYS ASN SEQRES 5 A 114 SER ALA GLN GLY ASN VAL TYR VAL LYS CYS PRO SER ILE SEQRES 6 A 114 ALA ALA ALA ILE ALA ALA VAL ASN ALA LEU HIS GLY ARG SEQRES 7 A 114 TRP PHE ALA GLY LYS MSE ILE THR ALA ALA TYR VAL PRO SEQRES 8 A 114 LEU PRO THR TYR HIS ASN LEU PHE PRO ASP SER MSE THR SEQRES 9 A 114 ALA THR GLN LEU LEU VAL PRO SER ARG ARG SEQRES 1 B 114 GLY VAL GLN PRO LEU ALA THR GLN CYS PHE GLN LEU SER SEQRES 2 B 114 ASN MSE PHE ASN PRO GLN THR GLU GLU GLU VAL GLY TRP SEQRES 3 B 114 ASP THR GLU ILE LYS ASP ASP VAL ILE GLU GLU CYS ASN SEQRES 4 B 114 LYS HIS GLY GLY VAL ILE HIS ILE TYR VAL ASP LYS ASN SEQRES 5 B 114 SER ALA GLN GLY ASN VAL TYR VAL LYS CYS PRO SER ILE SEQRES 6 B 114 ALA ALA ALA ILE ALA ALA VAL ASN ALA LEU HIS GLY ARG SEQRES 7 B 114 TRP PHE ALA GLY LYS MSE ILE THR ALA ALA TYR VAL PRO SEQRES 8 B 114 LEU PRO THR TYR HIS ASN LEU PHE PRO ASP SER MSE THR SEQRES 9 B 114 ALA THR GLN LEU LEU VAL PRO SER ARG ARG MODRES 3S6E MSE A 431 MET SELENOMETHIONINE MODRES 3S6E MSE A 500 MET SELENOMETHIONINE MODRES 3S6E MSE A 519 MET SELENOMETHIONINE MODRES 3S6E MSE B 431 MET SELENOMETHIONINE MODRES 3S6E MSE B 500 MET SELENOMETHIONINE MODRES 3S6E MSE B 519 MET SELENOMETHIONINE HET MSE A 431 13 HET MSE A 500 8 HET MSE A 519 13 HET MSE B 431 13 HET MSE B 500 8 HET MSE B 519 18 HET GOL A 601 6 HET GOL B 602 6 HET CIT B 603 13 HETNAM MSE SELENOMETHIONINE HETNAM GOL GLYCEROL HETNAM CIT CITRIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 CIT C6 H8 O7 FORMUL 6 HOH *386(H2 O) HELIX 1 1 GLY A 441 ASN A 455 1 15 HELIX 2 2 SER A 480 HIS A 492 1 13 HELIX 3 3 PRO A 507 PHE A 515 1 9 HELIX 4 4 PRO A 516 MSE A 519 5 4 HELIX 5 5 ASN B 433 GLU B 439 5 7 HELIX 6 6 GLY B 441 ASN B 455 1 15 HELIX 7 7 SER B 480 HIS B 492 1 13 HELIX 8 8 PRO B 507 PHE B 515 1 9 HELIX 9 9 PRO B 516 ALA B 521 5 6 SHEET 1 A 4 HIS A 462 VAL A 465 0 SHEET 2 A 4 VAL A 474 LYS A 477 -1 O TYR A 475 N TYR A 464 SHEET 3 A 4 CYS A 425 SER A 429 -1 N LEU A 428 O VAL A 474 SHEET 4 A 4 THR A 502 VAL A 506 -1 O ALA A 504 N GLN A 427 SHEET 1 B 2 TRP A 495 PHE A 496 0 SHEET 2 B 2 LYS A 499 MSE A 500 -1 O LYS A 499 N PHE A 496 SHEET 1 C 4 HIS B 462 VAL B 465 0 SHEET 2 C 4 VAL B 474 LYS B 477 -1 O TYR B 475 N TYR B 464 SHEET 3 C 4 CYS B 425 SER B 429 -1 N LEU B 428 O VAL B 474 SHEET 4 C 4 THR B 502 VAL B 506 -1 O ALA B 504 N GLN B 427 SHEET 1 D 2 TRP B 495 PHE B 496 0 SHEET 2 D 2 LYS B 499 MSE B 500 -1 O LYS B 499 N PHE B 496 LINK C ASN A 430 N MSE A 431 1555 1555 1.33 LINK C MSE A 431 N PHE A 432 1555 1555 1.33 LINK C LYS A 499 N MSE A 500 1555 1555 1.32 LINK C MSE A 500 N ILE A 501 1555 1555 1.33 LINK C SER A 518 N MSE A 519 1555 1555 1.34 LINK C MSE A 519 N THR A 520 1555 1555 1.33 LINK C ASN B 430 N MSE B 431 1555 1555 1.34 LINK C MSE B 431 N PHE B 432 1555 1555 1.32 LINK C LYS B 499 N MSE B 500 1555 1555 1.32 LINK C MSE B 500 N ILE B 501 1555 1555 1.34 LINK C SER B 518 N MSE B 519 1555 1555 1.33 LINK C MSE B 519 N THR B 520 1555 1555 1.33 SITE 1 AC1 10 GLN A 419 VAL A 488 HIS A 492 ALA A 503 SITE 2 AC1 10 SER A 528 ARG A 529 HOH A 637 HOH A 702 SITE 3 AC1 10 HOH A 707 HOH A 944 SITE 1 AC2 8 ASP A 466 ASN A 468 HIS B 492 ALA B 503 SITE 2 AC2 8 HOH B 644 HOH B 662 HOH B 846 HOH B 864 SITE 1 AC3 6 GLN A 471 GLU B 453 LYS B 456 HIS B 457 SITE 2 AC3 6 ARG B 494 HOH B 981 CRYST1 44.701 55.139 84.601 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022371 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018136 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011820 0.00000